Ruggie Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-300
Closed -$23K 338
2018
Q1
$23K Sell
300
-50
-14% -$4.03K 0.01% 193
2017
Q4
$30K Hold
350
0.02% 172
2017
Q3
$30K Hold
350
0.02% 153
2017
Q2
$29K Hold
350
0.02% 161
2017
Q1
$29K Hold
350
0.02% 134
2016
Q4
$26K Hold
350
0.03% 89
2016
Q3
$28K Buy
+350
New +$28K 0.03% 105
2016
Q2
Sell
-350
Closed -$25K 218
2016
Q1
$25K Buy
+350
New +$26.5K 0.03% 100
2015
Q4
Sell
-350
Closed -$28K 102
2015
Q3
$28K Buy
350
+56
+19% +$4.73K 0.03% 95
2015
Q2
$25K Sell
294
-56
-16% -$4.27K 0.02% 125
2015
Q1
$25K Sell
350
-358
-51% -$25.5K 0.03% 98
2014
Q4
$49K Buy
+708
New +$47.8K 0.04% 77

Other funds holding LLY

Ruggie Capital Group's LLY Position: Q2 2018 in Review

Ruggie Capital Group sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 300 shares — an estimated $23K sold.

Ruggie Capital Group first reported a position in LLY in Q4 2014 and held it in 12 quarters. The position peaked at $49K in Q4 2014. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Ruggie Capital Group reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Ruggie Capital Group sold 300 Eli Lilly shares in Q2 2018, an estimated $23K.
  • Ruggie Capital Group first reported a position in Eli Lilly in Q4 2014 and held it in 12 quarters.
  • Ruggie Capital Group's Eli Lilly position peaked at $49K in Q4 2014.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Ruggie Capital Group's 13F filing for Q2 2018, filed 15 Aug 2018.